FDA declines to approve Valeant's plaque psoriasis drug
June 18, 2018 at 08:09 AM EDT
June 18 (Reuters) - Valeant Pharmaceuticals International said on Monday that U.S. health regulators had declined to approve its drug to treat plaque psoriasis, citing questions related to certain data.
